Older adults with lung cancer may experience declines in life-space mobility during treatment, according to a study published.
An analysis of the 2019 Global Burden of Disease Study offers insight into rates and risk factors for respiratory tract cancers globally, regionally, and nationally.
The rates of invasive procedures after LDCT lung cancer screening are considerable and are associated with modest out-of-pocket costs.
The 12-month progression-free survival rate was superior in the lurbinectedin arm.
Racial/ethnic disparities in lung cancer screening persist, even in revised eligibility guidelines from the USPSTF.